THRX

Theseus Pharmaceuticals, Inc. Common Stock
THRX

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

THRX was delisted on the 13th of February, 2024.

Back to rankings

46 hedge funds and large institutions have $441M invested in Theseus Pharmaceuticals, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 46 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
46
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$214M
2
+$69.1M
3
+$40.7M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$16.2M
5
BC
Boxer Capital
California
+$11.3M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$214M
2
$69.1M
3
$40.7M
4
$16.2M
5
$11.3M
6
$9.66M
7
$9.02M
8
$7.92M
9
$7.75M
10
$6.76M
11
$6.64M
12
$6.17M
13
$5.95M
14
$5.54M
15
$5.19M
16
$3.17M
17
$3.17M
18
$2.6M
19
$2.44M
20
$1.61M
21
$1.27M
22
$1.24M
23
$1.23M
24
$713K
25
$393K
1
2